GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $27,753,000 | +1.1% | 637,575 | +1.2% | 0.07% | +14.3% |
| Q1 2022 | $27,438,000 | -2.6% | 629,907 | -1.4% | 0.06% | 0.0% |
| Q4 2021 | $28,184,000 | +16.0% | 639,112 | +0.5% | 0.06% | +3.3% |
| Q3 2021 | $24,307,000 | +8.5% | 636,151 | +13.0% | 0.06% | +7.0% |
| Q2 2021 | $22,412,000 | +20.7% | 562,832 | +8.2% | 0.06% | +7.5% |
| Q1 2021 | $18,573,000 | -2.3% | 520,411 | +0.7% | 0.05% | -7.0% |
| Q4 2020 | $19,010,000 | +1.5% | 516,579 | +3.8% | 0.06% | -10.9% |
| Q3 2020 | $18,728,000 | -2.9% | 497,560 | +5.3% | 0.06% | -12.3% |
| Q2 2020 | $19,282,000 | +14.9% | 472,715 | +6.8% | 0.07% | -6.4% |
| Q1 2020 | $16,775,000 | -17.3% | 442,747 | +2.6% | 0.08% | +1.3% |
| Q4 2019 | $20,277,000 | +6.1% | 431,533 | -3.6% | 0.08% | -6.1% |
| Q3 2019 | $19,106,000 | +10.3% | 447,665 | +3.4% | 0.08% | +7.9% |
| Q2 2019 | $17,329,000 | -1.1% | 433,026 | +3.3% | 0.08% | -6.2% |
| Q1 2019 | $17,520,000 | +11.7% | 419,242 | +2.1% | 0.08% | -2.4% |
| Q4 2018 | $15,687,000 | -7.2% | 410,557 | -2.5% | 0.08% | +2.5% |
| Q3 2018 | $16,907,000 | +1.5% | 420,893 | +1.8% | 0.08% | -6.9% |
| Q2 2018 | $16,661,000 | +17.5% | 413,313 | +13.9% | 0.09% | +13.0% |
| Q1 2018 | $14,174,000 | +20.7% | 362,777 | +9.5% | 0.08% | +20.3% |
| Q4 2017 | $11,747,000 | – | 331,185 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |